[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"app-context":3,"blog-regeneron-stock-has-rallied-36-in-six-months-here-is-why-four-expected-fda-approvals-could-push-it-higher-FR":222},{"languages":4,"categories":41,"products":125,"competitors":149},[5,9,13,17,21,25,29,33,37],{"name":6,"code":7,"id":8},"English","EN","TGFuZ3VhZ2U6ZW4=",{"name":10,"code":11,"id":12},"Español","ES","TGFuZ3VhZ2U6ZXM=",{"name":14,"code":15,"id":16},"Português","PT","TGFuZ3VhZ2U6cHQ=",{"name":18,"code":19,"id":20},"日本語","JA","TGFuZ3VhZ2U6amE=",{"name":22,"code":23,"id":24},"한국어","KO","TGFuZ3VhZ2U6a28=",{"name":26,"code":27,"id":28},"Deutsch","DE","TGFuZ3VhZ2U6ZGU=",{"name":30,"code":31,"id":32},"Italiano","IT","TGFuZ3VhZ2U6aXQ=",{"name":34,"code":35,"id":36},"Français","FR","TGFuZ3VhZ2U6ZnI=",{"name":38,"code":39,"id":40},"中文 (中国)","ZH","TGFuZ3VhZ2U6emg=",[42,73,104],{"icon":43,"slug":44,"title":45,"description":46,"featuredLinks":47},"mingcute:stock-line","stock-market-basics","Stock Market Basics","\u003Cp>Beginners' guides and practical tips for understanding stock market investing.\u003C\u002Fp>\n",[48,53,58,63,68],{"url":49,"title":50,"description":51,"ogImage":52},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-makes-stocks-go-up-and-down","What Makes Stocks Go Up and Down | TIKR.com","Understanding what makes stock prices go up and down can help investors better navigate investing. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-makes-stocks-go-up-and-down-banner\u002FWhat-makes-stocks-go-up-and-down-banner.jpg?_i=AA",{"url":54,"title":55,"description":56,"ogImage":57},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fdividend-yield-meaning-formula-example","Dividend Yield: Meaning, Formula, Example | Tikr.com Blog | TIKR.com","The dividend yield is a key metric for investors looking to gauge the income potential of their investments. It measures how much a company pays out in","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FDividend-yield\u002FDividend-yield.png?_i=AA",{"url":59,"title":60,"description":61,"ogImage":62},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmarket-capitalization-definition-formula-and-why-it-matters","Market Capitalization: Definition, Formula, and Why It Matters | TIKR.com","Long-term investors often look at various valuation metrics when deciding whether to invest in a particular company. One helpful metric to evaluate is","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters.png?_i=AA",{"url":64,"title":65,"description":66,"ogImage":67},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fearnings-per-share-definition-formula-and-why-eps-matters","Earnings Per Share: Definition, Formula, and Why EPS Matters | TIKR.com","Earnings Per Share (EPS) represents the portion of a company's net earnings allocated to each share. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEPS-Defiinition-formula-and-why-EPS-matters-1\u002FEPS-Defiinition-formula-and-why-EPS-matters-1.png?_i=AA",{"url":69,"title":70,"description":71,"ogImage":72},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-stock-price-target","What Is a Stock Price Target? | TIKR.com","A price target is a stock's estimated future price. It can help investors quickly find undervalued stocks. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-Stock-Price-Target-2\u002FWhat-is-a-Stock-Price-Target-2.png?_i=AA",{"icon":74,"slug":75,"title":76,"description":77,"featuredLinks":78},"material-symbols:analytics-outline","fundamental-analysis","Fundamental Analysis","\u003Cp>In-depth resources and financial metrics to help you evaluate companies like a pro.\u003C\u002Fp>\n",[79,84,89,94,99],{"url":80,"title":81,"description":82,"ogImage":83},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fshare-repurchase-why-do-companies-buy-back-their-stock","Share Repurchase: Why Do Companies Buy Back Their Stock? | TIKR.com","Share repurchases, or share buybacks, have gained popularity in the last two decades. According to a report from Goldman Sachs, stock buybacks initiated","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e.png?_i=AA",{"url":85,"title":86,"description":87,"ogImage":88},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-invested-capital","What Is a Good Return on Invested Capital? | TIKR.com","Learning about Return on Invested Capital (ROIC) can help investors spot highly profitable stocks that can drive long-term returns. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-Invested-capital\u002FWhat-is-a-good-return-on-Invested-capital.png?_i=AA",{"url":90,"title":91,"description":92,"ogImage":93},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-equity-ratio","What is a Good Return on Equity Ratio | Tikr.com Blog | TIKR.com","Return on Equity (ROE) is a financial ratio that reflects a company's profitability in relation to the equity invested by shareholders. It basically","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-equity-ratio-1\u002FWhat-is-a-good-return-on-equity-ratio-1.jpg?_i=AA",{"url":95,"title":96,"description":97,"ogImage":98},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio","What Is a Good P\u002FE Ratio? | TIKR.com","Financial analysts and investors look at various metrics before deciding whether a stock is a buy. One of the metrics is the price-to-earnings ratio (P\u002FE","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-PE-ratio-1\u002FWhat-is-a-good-PE-ratio-1.jpg?_i=AA",{"url":100,"title":101,"description":102,"ogImage":103},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Ftop-6-metrics-for-investing-in-reits","Top 6 Metrics for Investing in REITs | TIKR.com","Real estate has been one of the greatest asset classes for wealth creation in history, and investing in Real Estate Investment Trusts (REITs) can allow","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FGroup-10\u002FGroup-10.png?_i=AA",{"icon":105,"slug":106,"title":107,"description":108,"featuredLinks":109},"hugeicons:investigation","investing-lingo","Investing Lingo","\u003Cp>A comprehensive glossary of investing terms and jargon so you can speak the language of the markets confidently.\u003C\u002Fp>\n",[110,115,120],{"url":111,"title":112,"description":113,"ogImage":114},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fenterprise-value-definition-and-calculation","Enterprise Value: Definition and Calculation | Tikr.com Blog | TIKR.com","Enterprise value (EV) is a financial metric that offers a comprehensive snapshot of a company's total value. Unlike market capitalization which solely","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEnterprise-Value-Definition-and-Calculation_37576e40\u002FEnterprise-Value-Definition-and-Calculation_37576e40.png?_i=AA",{"url":116,"title":117,"description":118,"ogImage":119},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Febitda-definition-formula-how-to-use-it","EBITDA: Definition, Formula, How to Use It | TIKR.com","EBITDA stands for earnings before interest, taxes, depreciation and amortization. It's a financial metric commonly used to evaluate a company's financial","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEBITDA-Definition-Formula-How-to-Use-It\u002FEBITDA-Definition-Formula-How-to-Use-It.png?_i=AA",{"url":121,"title":122,"description":123,"ogImage":124},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-the-free-cash-flow-formula-and-why-does-it-matter","What is the Free Cash Flow Formula and Why Does It Matter | TIKR.com","Free cash flow, or FCF, is the cash a company generates after it accounts for outflows required to maintain business operations and support capital","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-the-free-cash-flow-formula\u002FWhat-is-the-free-cash-flow-formula.png?_i=AA",[126,130,134,137,141,145],{"slug":127,"modified":128,"title":129},"valuation-model-builder","2025-07-03T00:18:53","Value Stocks Quickly and Accurately",{"slug":131,"modified":132,"title":133},"stock-portfolio-tracking","2024-12-02T22:21:28","Monitor Your Portfolio",{"slug":75,"modified":135,"title":136},"2025-01-21T22:10:52","Instantly Analyze Companies with In-Depth Metrics",{"slug":138,"modified":139,"title":140},"stock-screener","2024-12-02T22:13:31","Find the Best Stocks to Buy",{"slug":142,"modified":143,"title":144},"investor-stock-portfolio","2025-01-21T22:02:56","Follow Investment Moves of Top Investors",{"slug":146,"modified":147,"title":148},"analyze-stocks","2025-07-23T16:04:24","Analyze Stocks",[150,154,158,162,166,170,174,178,182,186,190,194,198,202,206,210,214,218],{"slug":151,"title":152,"modified":153},"bloomberg","Bloomberg","2025-01-16T14:23:44",{"slug":155,"title":156,"modified":157},"morningstar","Morningstar","2025-01-16T14:25:16",{"slug":159,"title":160,"modified":161},"sentieo","Sentieo","2025-01-16T17:58:27",{"slug":163,"title":164,"modified":165},"googlefinance","Google Finance","2025-01-17T19:39:37",{"slug":167,"title":168,"modified":169},"tradingview","TradingView","2025-01-16T18:17:01",{"slug":171,"title":172,"modified":173},"factset","Factset","2025-01-16T18:20:16",{"slug":175,"title":176,"modified":177},"finviz","Finviz","2025-01-16T18:23:40",{"slug":179,"title":180,"modified":181},"ycharts","YCharts","2025-01-16T18:32:19",{"slug":183,"title":184,"modified":185},"marketbeat","MarketBeat","2025-03-11T00:27:23",{"slug":187,"title":188,"modified":189},"benzinga","Benzinga","2025-03-11T00:31:00",{"slug":191,"title":192,"modified":193},"gurufocus","Gurufocus","2025-03-11T00:31:12",{"slug":195,"title":196,"modified":197},"fast-graphs","FAST Graphs","2025-03-11T00:31:19",{"slug":199,"title":200,"modified":201},"tipranks","TipRanks","2025-03-11T00:31:26",{"slug":203,"title":204,"modified":205},"seeking-alpha","Seeking Alpha","2025-03-11T00:31:45",{"slug":207,"title":208,"modified":209},"thestreet","TheStreet","2025-03-11T00:31:52",{"slug":211,"title":212,"modified":213},"investing-com","Investing.com","2025-03-11T00:32:00",{"slug":215,"title":216,"modified":217},"zacks","Zacks","2025-03-26T15:40:40",{"slug":219,"title":220,"modified":221},"alphasense","AlphaSense","2025-03-11T00:32:15",{"post":223,"seo":259,"relatedPosts":266,"suggestedPosts":344},{"id":224,"title":225,"date":226,"modified":227,"excerpt":228,"content":229,"wordCount":230,"lang":231,"uri":232,"slug":233,"cloudinaryAssetId":234,"featuredImageOriginalUrl":235,"featuredImageMetadata":236,"author":239,"editor":245,"categories":250,"relatedPosts":256,"seo":257},93460,"Action Regeneron : Voici pourquoi quatre approbations attendues de la FDA pourraient pousser son rallye de 36% encore plus haut","2026-02-20T16:00:00","2026-02-20T06:08:52","\u003Cp>DUPIXENT de Regeneron a généré 17,8 milliards de dollars de ventes en 2025 pour seulement 8 indications, dont la plupart restent largement sous-pénétrées, et l'entreprise doit encore obtenir au moins 4 approbations de la FDA avant la fin de l'année.\u003C\u002Fp>\n","\n\u003Ch3 class=\"wp-block-heading\" id=\"h-key-stats-for-regeneron-pharmaceuticals-stock\">Statistiques clés pour l'action Regeneron Pharmaceuticals\u003C\u002Fh3>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Performance de cette semaine : \u003C\u002Fstrong>-3%\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Fourchette de 52 semaines : \u003C\u002Fstrong> 476 $ à 821\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Prix actuel : \u003C\u002Fstrong> 762\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>La plupart des investisseurs ne savent jamais si une action est réellement sous-évaluée ou surévaluée. Les outils d'évaluation de qualité professionnelle de TIKR vous donnent une réponse claire et étayée par des données sur plus de 60 000 actions, et ce gratuitement.\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-what-happened-to-regeneron-stock\">\u003Cstrong>Qu'est-il arrivé à l'action Regeneron ?\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>Les actions de Regeneron Pharmaceuticals\u003Ca href=\"https:\u002F\u002Fwww.tikr.com\u002F&ref=tikrblog\">(REGN\u003C\u002Fa>) ont clôturé à 782 $ hier, se négociant à une distance frappante de leur sommet de 52 semaines de 821,11 $ et se maintenant près des sommets de plusieurs mois, alors qu'un flux constant de catalyseurs de pipeline continue de renforcer la confiance des investisseurs à l'approche d'un pivot de 2026.\u003C\u002Fp>\n\n\n\n\u003Cp>Hier encore, la \u003Ca href=\"https:\u002F\u002Fnewsroom.regeneron.com\u002Fnews-releases\u002Fnews-release-details\u002Fgaretosmab-biologics-license-application-accepted-fda-priority\">FDA a accepté la BLA de Regeneron\u003C\u002Fa> pour le garetosmab dans le cadre d'une évaluation prioritaire pour la FOP, une maladie débilitante très rare où les tissus mous sont progressivement remplacés par des os anormaux, avec une date d'action cible d'août 2026.\u003C\u002Fp>\n\n\n\n\u003Cp>Les données sur le garetosmab qui sous-tendent la demande sont frappantes, l'essai de phase 3 OPTIMA ayant montré une réduction de 94 % des nouvelles lésions osseuses hétérotopiques à la dose de 3 mg\u002Fkg par rapport au placebo et une réduction de plus de 99 % du volume total des lésions, des résultats que le PDG, Leonard Schleifer, a qualifiés de sans précédent.\u003C\u002Fp>\n\n\n\n\u003Cp>Le marché considère de moins en moins Regeneron comme une histoire à deux produits DUPIXENT et EYLEA, mais plutôt comme une plateforme diversifiée en phase finale, avec au moins 4 approbations de la FDA attendues en 2026, 18 nouvelles études de phase 3 en cours, et des données sur le mélanome fianlimab plus LIBTAYO encore à venir au premier semestre 2026.\u003C\u002Fp>\n\n\n\n\u003Cp>DUPIXENT a réalisé 17,8 milliards de dollars de ventes mondiales sur l'ensemble de l'année 2025, avec plus de 1,4 million de patients sous traitement dans 8 indications approuvées, tandis qu'EYLEA HD a progressé de 66 % au quatrième trimestre pour atteindre 506 millions de dollars, ce qui donne à la société deux moteurs commerciaux de composition qui financent l'un des pipelines les plus profonds de la biotech à grande capitalisation.\u003C\u002Fp>\n\n\n\n\u003Cp>Avec la décision sur le garetosmab attendue en août, les résultats du fianlimab au premier semestre, la demande d'autorisation de mise sur le marché du cemdisiran gMG au premier trimestre et le lancement d'un programme clinique combiné GLP\u002FPCSK9 plus tard dans l'année, 2026 représente l'année la plus riche en catalyseurs de l'histoire de Regeneron et l'argument le plus clair à ce jour que sa valorisation ne reflète qu'une fraction du potentiel de son portefeuille de produits.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Découvrez le moment exact où Wall Street revalorise une action avant le reste du marché - suivez les changements de notation des analystes en temps réel avec TIKR gratuitement →\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-where-is-the-regeneron-stock-headed\">\u003Cstrong>Où va l'action Regeneron ?\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>L'acceptation de l'examen prioritaire du garetosmab ajoute une date concrète de décision de la FDA en août 2026 à un pipeline qui comprend déjà des données sur le mélanome fianlimab au premier semestre, une soumission de cemdisiran gMG au premier trimestre et une décision de thérapie génique DB-OTO, ce qui fait des six prochains mois la période la plus riche en catalyseurs de l'histoire de Regeneron.\u003C\u002Fp>\n\n\n\n\u003Cp>Le cas fondamental a son propre poids, avec les estimations de la rue prévoyant des revenus 2026 de 15,63 milliards de dollars (+9% par rapport à l'année précédente) et des BPA normalisés de 44,69 dollars, soutenus par la base de 17,8 milliards de dollars de DUPIXENT pour l'année 2025, la croissance de 66% d'EYLEA HD au quatrième trimestre et les marges de revenu nettes qui se maintiennent au-dessus de 31%.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"844\" height=\"562\" data-public-id=\"images\u002Fimage-250\u002Fimage-250.png\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_844,h_562,c_scale\u002Ff_webp,q_auto\u002Fv1771566572\u002Fimages\u002Fimage-250\u002Fimage-250.png?_i=AA\" alt=\"regeneron stock\" class=\"wp-post-93460 wp-image-93463\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1771566572\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1771566572\u002Fimages\u002Fimage-250\u002Fimage-250.png?_i=AA 844w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_200,c_scale\u002Ff_webp,q_auto\u002Fv1771566572\u002Fimages\u002Fimage-250\u002Fimage-250.png?_i=AA 300w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_511,c_scale\u002Ff_webp,q_auto\u002Fv1771566572\u002Fimages\u002Fimage-250\u002Fimage-250.png?_i=AA 768w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771566572\u002Fimages\u002Fimage-250\u002Fimage-250.png?_i=AA 600w\" sizes=\"auto, (max-width: 844px) 100vw, 844px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Cible des analystes de la rue pour l'action REGN \u003Cstrong>(\u003C\u002Fstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>TIKR\u003C\u002Fstrong>\u003C\u002Fa>\u003Cstrong>)\u003C\u002Fstrong>\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>17 analystes considèrent REGN comme un achat et 2 comme une surperformance en date du 19 février, avec un objectif de prix moyen de 868,04 $, ce qui implique une hausse d'environ 11 % par rapport au prix actuel de 782,38 $, un écart relativement modeste qui reflète l'ampleur du pipeline que les haussiers ont déjà intégré dans leurs prix.\u003C\u002Fp>\n\n\n\n\u003Cp>La fourchette cible s'étend d'un minimum de 730 $ à un maximum de 1 057 $, un écart qui reflète tout le débat entre ceux qui considèrent les vents contraires des biosimilaires d'EYLEA et le ralentissement de la croissance du BPA comme des obstacles structurels et ceux qui croient que le fianlimab et les programmes relatifs au facteur XI et à l'obésité représentent la prochaine vague de plusieurs milliards de dollars.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg width=\"1024\" height=\"832\" data-public-id=\"images\u002FREGN_valuation_model_9346528184\u002FREGN_valuation_model_9346528184.webp\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_832,c_scale\u002Ff_webp,q_auto\u002Fv1771566943\u002Fimages\u002FREGN_valuation_model_9346528184\u002FREGN_valuation_model_9346528184.webp?_i=AA\" alt=\"regeneron stock\" class=\"wp-post-93460 wp-image-93465\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1771566943\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_832,c_scale\u002Ff_webp,q_auto\u002Fv1771566943\u002Fimages\u002FREGN_valuation_model_9346528184\u002FREGN_valuation_model_9346528184.webp?_i=AA 1024w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_244,c_scale\u002Ff_webp,q_auto\u002Fv1771566943\u002Fimages\u002FREGN_valuation_model_9346528184\u002FREGN_valuation_model_9346528184.webp?_i=AA 300w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_624,c_scale\u002Ff_webp,q_auto\u002Fv1771566943\u002Fimages\u002FREGN_valuation_model_9346528184\u002FREGN_valuation_model_9346528184.webp?_i=AA 768w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1536,h_1248,c_scale\u002Ff_webp,q_auto\u002Fv1771566943\u002Fimages\u002FREGN_valuation_model_9346528184\u002FREGN_valuation_model_9346528184.webp?_i=AA 1536w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_2048,h_1663,c_scale\u002Ff_webp,q_auto\u002Fv1771566943\u002Fimages\u002FREGN_valuation_model_9346528184\u002FREGN_valuation_model_9346528184.webp?_i=AA 2048w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1200,h_975,c_scale\u002Ff_webp,q_auto\u002Fv1771566943\u002Fimages\u002FREGN_valuation_model_9346528184\u002FREGN_valuation_model_9346528184.webp?_i=AA 1200w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_1137,c_scale\u002Ff_webp,q_auto\u002Fv1771566943\u002Fimages\u002FREGN_valuation_model_9346528184\u002FREGN_valuation_model_9346528184.webp?_i=AA 1400w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Résultats du modèle d'évaluation de l'action REGN\u003Cstrong> (\u003C\u002Fstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=21127&tid=2621295&ref=tikrblog\">\u003Cstrong>TIKR\u003C\u002Fstrong>\u003C\u002Fa>\u003Cstrong>)\u003C\u002Fstrong>\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>Le modèle d'évaluation de TIKR, basé sur un pipeline dont la direction s'attend à ce qu'il génère au moins 4 approbations de la FDA en 2026, évalue REGN à 1 226,75 $ d'ici décembre 2030, ce qui implique un rendement total de 56,8 % et un TRI annualisé de 9,7 % par rapport aux niveaux actuels, alors que le cycle des nouveaux produits absorbe le déclin de l'EYLEA.\u003C\u002Fp>\n\n\n\n\u003Cp>Regeneron augmente ses dépenses en R&D de 5,9 à 6,1 milliards de dollars pour financer 18 nouvelles études de phase 3, ce qui comprime les marges EBITDA de 61,2 % en 2021 à 35,3 % en 2026, et le modèle prévoit une contraction annuelle supplémentaire de 2 % du ratio cours\u002Fbénéfice à mesure que le marché évalue ce cycle de dépenses.\u003C\u002Fp>\n\n\n\n\u003Cp>À 782,38 $, Regeneron semble légèrement sous-évalué par rapport à la profondeur et à la densité à court terme de son pipeline, mais la véritable opportunité de hausse dépend du fait que le fianlimab fournisse une lecture claire du mélanome au premier semestre et que le garetosmab reçoive l'approbation de la FDA en août, deux événements binaires qui définiront la trajectoire de l'action pour le reste de l'année 2026.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Ne manquez pas le prochain mouvement de l'action REGN. Suivez gratuitement les cibles des analystes, les jalons du pipeline et les surprises en matière de bénéfices sur Regeneron Pharmaceuticals avec TIKR →.\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-value-any-stock-in-under-60-seconds-it-s-free\">Évaluer n'importe quelle action en moins de 60 secondes (c'est gratuit)\u003C\u002Fh2>\n\n\n\n\u003Cp>Avec le nouveau modèle d'évaluation de TIKR, vous pouvez estimer le prix potentiel d'une action en moins d'une minute.\u003C\u002Fp>\n\n\n\n\u003Cp>Il vous suffit d'entrer trois données simples :\u003C\u002Fp>\n\n\n\n\u003Col class=\"wp-block-list\">\n\u003Cli>\u003Cem>Croissance du chiffre d'affaires\u003C\u002Fem>\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cem>Marges d'exploitation\u003C\u002Fem>\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cem>Multiple P\u002FE de sortie\u003C\u002Fem>\u003C\u002Fli>\n\u003C\u002Fol>\n\n\n\n\u003Cp>TIKR calcule ensuite le prix potentiel de l'action et le rendement total dans le cadre de scénarios haussier, baissier et de base, ce qui vous permet de déterminer rapidement si une action est sous-évaluée ou surévaluée.\u003C\u002Fp>\n\n\n\n\u003Cp>Si vous n'êtes pas sûr de ce qu'il faut saisir, TIKR remplit automatiquement chaque entrée en utilisant les estimations consensuelles des analystes, ce qui vous donne un point de départ rapide et fiable.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Les meilleures idées de Wall Street ne restent pas longtemps cachées. TIKR vous permet d'être au courant des mises à jour des analystes, des résultats supérieurs aux attentes et des surprises en matière de revenus pour des milliers d'actions dès qu'elles se produisent, et ce gratuitement.\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n",868,"fr","\u002Fblog\u002Fregeneron-stock-has-rallied-36-in-six-months-here-is-why-four-expected-fda-approvals-could-push-it-higher","regeneron-stock-has-rallied-36-in-six-months-here-is-why-four-expected-fda-approvals-could-push-it-higher","images\u002FFEATURED-IMAGE-MAKER-265\u002FFEATURED-IMAGE-MAKER-265","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1771567532\u002Fimages\u002FFEATURED-IMAGE-MAKER-265\u002FFEATURED-IMAGE-MAKER-265.png?_i=AA",{"altText":237,"imageCredit":238},"Regeneron Stock: Here’s Why Four Expected FDA Approvals Could Push its 36% Rally Even Higher","TIKR",{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":244},"Gian Estrada","giantikr","author","",[],{"name":246,"slug":247,"role":248,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":249},"Thomas Richmond","thomastikr","editor",[],[251],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},"Examens des Actions","reviews","\u002Fblog\u002Fcategory\u002Freviews",0,[],{"title":237,"metaDesc":258,"opengraphDescription":258,"twitterTitle":237,"twitterDescription":258},"Regeneron’s DUPIXENT generated $17.8 billion in 2025 sales across just 8 indications, most of which remain significantly underpenetrated, and the company still has at least 4 FDA approvals expected before the year is out.",{"title":237,"description":260,"twitterTitle":237,"twitterDescription":260,"author":240,"articlePublisher":261,"articlePublishedTime":226,"articleModifiedTime":227,"twitterLabel1":262,"twitterData1":263,"ogTitle":237,"ogDescription":260,"ogUrl":232,"ogImage":235,"ogImageWidth":264,"ogImageHeight":265,"ogImageSecureUrl":235,"ogImageAlt":237,"twitterImage":235},"Regeneron’s DUPIXENT generated $17.8 billion in 2025 sales across just 8 indications, most of which remain significantly underpenetrated, and the company still has at least 4 FDA approvals expected before the year is out.","TIKR.com","Temps de lecture estimé","7 minutes",1200,630,[267,282,297,312,327],{"id":255,"title":268,"date":269,"excerpt":270,"wordCount":271,"uri":272,"slug":273,"cloudinaryAssetId":274,"featuredImageOriginalUrl":275,"featuredImageMetadata":276,"author":277,"categories":279,"relatedPosts":281},"L'action Boston Scientific a baissé de 20 % cette année. Voici ce que les investisseurs doivent savoir avant le 28 mars","2026-02-20 16:12:00","L'action Boston Scientific a chuté de 31 % par rapport à son plus haut niveau sur 52 semaines, mais 25 analystes la considèrent toujours comme un achat avec un objectif moyen de 104,75 $ - et l'essai CHAMPION pourrait tout changer le 28 mars.",824,"\u002Fblog\u002Fboston-scientific-stock-is-down-20-this-year-here-is-what-investors-need-to-know-before-march-28","boston-scientific-stock-is-down-20-this-year-here-is-what-investors-need-to-know-before-march-28","images\u002FFEATURED-IMAGE-MAKER-264\u002FFEATURED-IMAGE-MAKER-264","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1771565687\u002Fimages\u002FFEATURED-IMAGE-MAKER-264\u002FFEATURED-IMAGE-MAKER-264.png?_i=AA",{"altText":268},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":278},[],[280],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":283,"date":284,"excerpt":285,"wordCount":286,"uri":287,"slug":288,"cloudinaryAssetId":289,"featuredImageOriginalUrl":290,"featuredImageMetadata":291,"author":292,"categories":294,"relatedPosts":296},"L'action UPS n'a pas bougé depuis l'année dernière. Voici pourquoi 2026 pourrait être le point d'inflexion","2026-02-20 15:30:00","UPS a réduit ses bénéfices par action quatre années de suite et les analystes prévoient une nouvelle baisse de 1,3 % en 2026. L'objectif de cours moyen étant inférieur au cours actuel de l'action, la thèse de la reprise repose entièrement sur une date : juin 2026.",866,"\u002Fblog\u002Fups-stock-is-flat-since-last-year-heres-why-2026-could-be-the-turning-point","ups-stock-is-flat-since-last-year-heres-why-2026-could-be-the-turning-point","images\u002FFEATURED-IMAGE-MAKER-270_93523d2769\u002FFEATURED-IMAGE-MAKER-270_93523d2769","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1771597556\u002Fimages\u002FFEATURED-IMAGE-MAKER-270_93523d2769\u002FFEATURED-IMAGE-MAKER-270_93523d2769.png?_i=AA",{"altText":283},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":293},[],[295],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":298,"date":299,"excerpt":300,"wordCount":301,"uri":302,"slug":303,"cloudinaryAssetId":304,"featuredImageOriginalUrl":305,"featuredImageMetadata":306,"author":307,"categories":309,"relatedPosts":311},"L'action d'Abbott Laboratories est en baisse de 16 % par rapport à son sommet de 52 semaines. Voici où l'action pourrait aller en 2026","2026-02-20 14:54:00","L'activité CGM d'Abbott Laboraties vient de franchir la barre des 7,5 milliards de dollars de ventes annuelles, avec une croissance de plus d'un milliard de dollars pour la troisième année consécutive, et cette piste n'a pas encore atteint le marché des produits non insuliniques qui pourrait éclipser tout ce qui l'a précédé.",780,"\u002Fblog\u002Fabbott-laboratories-stock-is-down-16-from-its-52-week-high-heres-where-the-stock-could-go-in-2026","abbott-laboratories-stock-is-down-16-from-its-52-week-high-heres-where-the-stock-could-go-in-2026","images\u002FFEATURED-IMAGE-MAKER-261_934137d18d\u002FFEATURED-IMAGE-MAKER-261_934137d18d","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1771557105\u002Fimages\u002FFEATURED-IMAGE-MAKER-261_934137d18d\u002FFEATURED-IMAGE-MAKER-261_934137d18d.png?_i=AA",{"altText":298},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":308},[],[310],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":313,"date":314,"excerpt":315,"wordCount":316,"uri":317,"slug":318,"cloudinaryAssetId":319,"featuredImageOriginalUrl":320,"featuredImageMetadata":321,"author":322,"categories":324,"relatedPosts":326},"GE HealthCare après une triple autorisation de la FDA : Voici où l'action pourrait aller en 2026","2026-02-20 14:00:00","Wall Street a passé trois ans à considérer GE HealthCare comme une société d'imagerie à croissance lente. Les triples autorisations de la FDA, le contrat BARDA AI et la montée en puissance de Flyrcado, qui vise 500 millions de dollars d'ici à 2028, rendent ce discours plus difficile à défendre.\n",749,"\u002Fblog\u002Fge-healthcare-after-triple-fda-clearance-heres-where-the-stock-could-go-in-2026","ge-healthcare-after-triple-fda-clearance-heres-where-the-stock-could-go-in-2026","images\u002FFEATURED-IMAGE-MAKER-263\u002FFEATURED-IMAGE-MAKER-263","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1771559801\u002Fimages\u002FFEATURED-IMAGE-MAKER-263\u002FFEATURED-IMAGE-MAKER-263.png?_i=AA",{"altText":313},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":323},[],[325],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":328,"date":329,"excerpt":330,"wordCount":331,"uri":332,"slug":333,"cloudinaryAssetId":334,"featuredImageOriginalUrl":335,"featuredImageMetadata":336,"author":337,"categories":341,"relatedPosts":343},"Newmont a fait un bond de 86% au cours des 6 derniers mois. Voici ce qui nous attend en 2026","2026-02-20 13:35:00","L'action Newmont a grimpé d'environ 86 % au cours des six derniers mois, mais la faiblesse récente reflète la baisse des prévisions de production pour 2026 et l'augmentation des dépenses d'investissement. Voici pourquoi le flux de trésorerie disponible record et les marges solides continuent de façonner les perspectives pour 2026.",704,"\u002Fblog\u002Fnewmont-surged-86-in-the-last-6-months-heres-what-to-expect-in-2026","newmont-surged-86-in-the-last-6-months-heres-what-to-expect-in-2026","images\u002F@Tatsiana-Kalasouskaya-from-Изображения-пользователя-Tatsiana-Kalasouskaya-via-Canva\u002F@Tatsiana-Kalasouskaya-from-Изображения-пользователя-Tatsiana-Kalasouskaya-via-Canva","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771590583\u002Fimages\u002F@Tatsiana-Kalasouskaya-from-Изображения-пользователя-Tatsiana-Kalasouskaya-via-Canva\u002F@Tatsiana-Kalasouskaya-from-Изображения-пользователя-Tatsiana-Kalasouskaya-via-Canva.png?_i=AA",{"altText":328},{"name":338,"slug":339,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":340},"Nikko Henson","nikkotikr",[],[342],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],[345,365,380,394,409,424,444,459,474,489,504],{"id":255,"title":346,"date":347,"excerpt":348,"wordCount":349,"uri":350,"slug":351,"cloudinaryAssetId":352,"featuredImageOriginalUrl":353,"featuredImageMetadata":354,"author":355,"categories":359,"relatedPosts":364},"L'action SMCI s'envole de 8 % suite à l'explosion des revenus de l'IA de 12,6 milliards de dollars : Voici où l'action pourrait aller en 2026","2026-02-20 15:00:00","Les actions de Super Micro Computer se sont redressées à la suite d'un rapport explosif sur les résultats du deuxième trimestre, qui a pulvérisé les estimations de Wall Street en matière de recettes. ",906,"\u002Fblog\u002Fsmci-stock-rallies-20-on-12-6b-ai-revenue-explosion-heres-where-the-stock-could-go-in-2026","smci-stock-rallies-20-on-12-6b-ai-revenue-explosion-heres-where-the-stock-could-go-in-2026","images\u002F8-8\u002F8-8","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771562724\u002Fimages\u002F8-8\u002F8-8.png?_i=AA",{"altText":346},{"name":356,"slug":357,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":358},"Wiltone Asuncion","wiltonetikr",[],[360],{"name":361,"slug":362,"uri":363,"description":243,"postsCount":255},"Investissement Général","general-investing","\u002Fblog\u002Fcategory\u002Fgeneral-investing",[],{"id":255,"title":366,"date":367,"excerpt":368,"wordCount":369,"uri":370,"slug":371,"cloudinaryAssetId":372,"featuredImageOriginalUrl":373,"featuredImageMetadata":374,"author":375,"categories":377,"relatedPosts":379},"Les actions de Texas Pacific Land augmentent de 10 % grâce à des redevances record : Voici où l'action pourrait aller en 2026","2026-02-20 14:30:00","Les actions de Texas Pacific Land ont grimpé à la suite d'un incroyable rapport sur les bénéfices qui mettait en évidence une production record de redevances et une augmentation massive des dividendes.",853,"\u002Fblog\u002Ftexas-pacific-land-stock-rallies-10-on-record-royalties-heres-where-the-stock-could-go-in-2026","texas-pacific-land-stock-rallies-10-on-record-royalties-heres-where-the-stock-could-go-in-2026","images\u002F7-8\u002F7-8","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771562702\u002Fimages\u002F7-8\u002F7-8.png?_i=AA",{"altText":366},{"name":356,"slug":357,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":376},[],[378],{"name":361,"slug":362,"uri":363,"description":243,"postsCount":255},[],{"id":255,"title":381,"date":382,"excerpt":383,"wordCount":369,"uri":384,"slug":385,"cloudinaryAssetId":386,"featuredImageOriginalUrl":387,"featuredImageMetadata":388,"author":389,"categories":391,"relatedPosts":393},"L'action Carvana chute de 8 % à la suite de l'événement \"Sell the News\" : Les analystes voient-ils une reprise en 2026 ?","2026-02-20 13:30:00","Les actions de Carvana ont chuté après la publication des résultats du quatrième trimestre, mais ce n'est pas parce que les chiffres étaient mauvais. En fait, la société a dépassé les estimations de bénéfices. ","\u002Fblog\u002Fcarvana-stock-drops-8-on-sell-the-news-event-do-analysts-see-a-recovery-in-2026","carvana-stock-drops-8-on-sell-the-news-event-do-analysts-see-a-recovery-in-2026","images\u002F5-8_934356b76c\u002F5-8_934356b76c","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771562666\u002Fimages\u002F5-8_934356b76c\u002F5-8_934356b76c.png?_i=AA",{"altText":381},{"name":356,"slug":357,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":390},[],[392],{"name":361,"slug":362,"uri":363,"description":243,"postsCount":255},[],{"id":255,"title":395,"date":396,"excerpt":397,"wordCount":398,"uri":399,"slug":400,"cloudinaryAssetId":401,"featuredImageOriginalUrl":402,"featuredImageMetadata":403,"author":404,"categories":406,"relatedPosts":408},"L'action de Pool Corp plonge de 14 % en raison de la stagnation des constructions de piscines : Voici où l'action pourrait se diriger en 2026","2026-02-20 13:00:00","Les actions de Pool Corporation ont chuté à la suite de la publication de résultats médiocres pour le quatrième trimestre, qui ont mis en évidence la faiblesse persistante de la construction de nouvelles piscines et des dépenses discrétionnaires. ",782,"\u002Fblog\u002Fpool-corp-stock-plunges-14-on-sluggish-pool-builds-heres-where-the-stock-could-be-headed-in-2026","pool-corp-stock-plunges-14-on-sluggish-pool-builds-heres-where-the-stock-could-be-headed-in-2026","images\u002F4-8_93434d8e89\u002F4-8_93434d8e89","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771562650\u002Fimages\u002F4-8_93434d8e89\u002F4-8_93434d8e89.png?_i=AA",{"altText":395},{"name":356,"slug":357,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":405},[],[407],{"name":361,"slug":362,"uri":363,"description":243,"postsCount":255},[],{"id":255,"title":410,"date":411,"excerpt":412,"wordCount":413,"uri":414,"slug":415,"cloudinaryAssetId":416,"featuredImageOriginalUrl":417,"featuredImageMetadata":418,"author":419,"categories":421,"relatedPosts":423},"L'action Deere bondit de 11 % alors que le cycle agricole touche le fond : Voici où l'action pourrait se diriger en 2026","2026-02-20 12:30:00","Les actions de Deere & Company sont montées en flèche à la suite de la publication d'un résultat largement supérieur à celui du premier trimestre et d'un relèvement des prévisions de bénéfices pour 2026. ",836,"\u002Fblog\u002Fdeere-stock-surges-11-as-the-farm-cycle-bottoms-heres-where-the-stock-could-be-headed-in-2026","deere-stock-surges-11-as-the-farm-cycle-bottoms-heres-where-the-stock-could-be-headed-in-2026","images\u002F3-8_934332ab13\u002F3-8_934332ab13","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771562637\u002Fimages\u002F3-8_934332ab13\u002F3-8_934332ab13.png?_i=AA",{"altText":410},{"name":356,"slug":357,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":420},[],[422],{"name":361,"slug":362,"uri":363,"description":243,"postsCount":255},[],{"id":255,"title":425,"date":426,"excerpt":427,"wordCount":428,"uri":429,"slug":430,"cloudinaryAssetId":431,"featuredImageOriginalUrl":432,"featuredImageMetadata":433,"author":434,"categories":438,"relatedPosts":443},"En baisse de 30 % en trois mois, l'action BlackLine peut-elle se rétablir en 2026 ?","2026-02-20 10:54:00","L'action BlackLine a perdu 30 % en trois mois - mais les réservations record, la dynamique de l'IA et l'adoption de la plateforme pourraient entraîner une hausse de 38,7 % d'ici décembre 2028.",1258,"\u002Fblog\u002Fdown-30-in-3-months-can-blackline-nasdaq-stock-recover-in-2026","down-30-in-3-months-can-blackline-nasdaq-stock-recover-in-2026","images\u002FBL-stock\u002FBL-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771422160\u002Fimages\u002FBL-stock\u002FBL-stock.png?_i=AA",{"altText":425},{"name":435,"slug":436,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":437},"Aditya Raghunath","adityatikr",[],[439],{"name":440,"slug":441,"uri":442,"description":243,"postsCount":255},"Évaluation","valuation","\u002Fblog\u002Fcategory\u002Fvaluation",[],{"id":255,"title":445,"date":446,"excerpt":447,"wordCount":448,"uri":449,"slug":450,"cloudinaryAssetId":451,"featuredImageOriginalUrl":452,"featuredImageMetadata":453,"author":454,"categories":456,"relatedPosts":458},"En baisse de 45 % par rapport à ses plus hauts niveaux historiques, l'action Agilysys peut-elle enfin se redresser en 2026 ?","2026-02-20 10:15:00","L'action Agilysys pourrait rapporter 30 % par an jusqu'en 2030 - voici ce que disent les chiffres après un troisième trimestre record et le déploiement en cours du PMS de Marriott.",1268,"\u002Fblog\u002Fdown-45-from-all-time-highs-can-agilysys-nasdaq-stock-finally-recover-in-2026","down-45-from-all-time-highs-can-agilysys-nasdaq-stock-finally-recover-in-2026","images\u002FAGYS-stock\u002FAGYS-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771434554\u002Fimages\u002FAGYS-stock\u002FAGYS-stock.png?_i=AA",{"altText":445},{"name":435,"slug":436,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":455},[],[457],{"name":440,"slug":441,"uri":442,"description":243,"postsCount":255},[],{"id":255,"title":460,"date":461,"excerpt":462,"wordCount":463,"uri":464,"slug":465,"cloudinaryAssetId":466,"featuredImageOriginalUrl":467,"featuredImageMetadata":468,"author":469,"categories":471,"relatedPosts":473},"En baisse de 13% au cours des 12 derniers mois, l'action RingCentral peut-elle offrir de meilleurs rendements en 2026 ?","2026-02-20 10:05:00","RingCentral s'oriente vers les communications alimentées par l'IA avec de nouveaux produits qui stimulent la croissance. L'analyse du titre montre un potentiel de hausse de 15,5 % malgré la récente baisse de 20 %.",1267,"\u002Fblog\u002Fdown-13-in-last-12-months-can-ringcentral-nyse-stock-deliver-better-returns-in-2026","down-13-in-last-12-months-can-ringcentral-nyse-stock-deliver-better-returns-in-2026","images\u002FRNG-stock\u002FRNG-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771481708\u002Fimages\u002FRNG-stock\u002FRNG-stock.png?_i=AA",{"altText":460},{"name":435,"slug":436,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":470},[],[472],{"name":440,"slug":441,"uri":442,"description":243,"postsCount":255},[],{"id":255,"title":475,"date":476,"excerpt":477,"wordCount":478,"uri":479,"slug":480,"cloudinaryAssetId":481,"featuredImageOriginalUrl":482,"featuredImageMetadata":483,"author":484,"categories":486,"relatedPosts":488},"En baisse de 13 % au cours des 12 derniers mois, l'action OneStream peut-elle offrir de meilleurs rendements en 2026 ?","2026-02-20 10:00:00","Analyse de l'action OneStream : La plateforme financière alimentée par l'IA présente un potentiel de hausse de 50 %. SensibleAI améliore le retour sur investissement des clients grâce à des cycles de prévision 90 % plus rapides.",1368,"\u002Fblog\u002Fdown-13-in-last-12-months-can-onestream-nasdaq-os-stock-deliver-better-returns-in-2026","down-13-in-last-12-months-can-onestream-nasdaq-os-stock-deliver-better-returns-in-2026","images\u002FOS-stock\u002FOS-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771495115\u002Fimages\u002FOS-stock\u002FOS-stock.png?_i=AA",{"altText":475},{"name":435,"slug":436,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":485},[],[487],{"name":440,"slug":441,"uri":442,"description":243,"postsCount":255},[],{"id":255,"title":490,"date":491,"excerpt":492,"wordCount":493,"uri":494,"slug":495,"cloudinaryAssetId":496,"featuredImageOriginalUrl":497,"featuredImageMetadata":498,"author":499,"categories":501,"relatedPosts":503},"En baisse de 51 % au cours des 12 derniers mois, l'action nCino peut-elle offrir de meilleurs rendements en 2026 ?","2026-02-20 09:55:00","Analyse des actions nCino : La plateforme bancaire alimentée par l'IA montre une forte dynamique avec une croissance de 11% du chiffre d'affaires. L'objectif de cours de 19 dollars implique une hausse de 19 %, soit un rendement annuel de 9 %.",1367,"\u002Fblog\u002Fdown-51-in-last-12-months-can-ncino-nasdaq-ncno-stock-deliver-better-returns-in-2026","down-51-in-last-12-months-can-ncino-nasdaq-ncno-stock-deliver-better-returns-in-2026","images\u002FNCNO-stock\u002FNCNO-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771484199\u002Fimages\u002FNCNO-stock\u002FNCNO-stock.png?_i=AA",{"altText":490},{"name":435,"slug":436,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":500},[],[502],{"name":440,"slug":441,"uri":442,"description":243,"postsCount":255},[],{"id":255,"title":505,"date":506,"excerpt":507,"wordCount":508,"uri":509,"slug":510,"cloudinaryAssetId":511,"featuredImageOriginalUrl":512,"featuredImageMetadata":513,"author":514,"categories":516,"relatedPosts":521},"L'action Amazon entre dans un marché baissier technique alors que la rotation technologique anéantit les gains récents","2026-02-20 10:45:00","L'action d'Amazon a chuté de 8 % et s'est retrouvée en territoire baissier après que l'entreprise a annoncé son intention de consacrer 200 milliards de dollars à l'infrastructure de l'IA, soit 53 milliards de dollars de plus que prévu.",832,"\u002Fblog\u002Famazon-nasdaq-stock-enters-technical-bear-market-as-tech-rotation-wipes-out-recent-gains","amazon-nasdaq-stock-enters-technical-bear-market-as-tech-rotation-wipes-out-recent-gains","images\u002FAMZN-stock_932075ae4e\u002FAMZN-stock_932075ae4e","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771421355\u002Fimages\u002FAMZN-stock_932075ae4e\u002FAMZN-stock_932075ae4e.png?_i=AA",{"altText":505},{"name":435,"slug":436,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":515},[],[517],{"name":518,"slug":519,"uri":520,"description":243,"postsCount":255},"Mises à Jour des Résultats","earnings-updates","\u002Fblog\u002Fcategory\u002Fearnings-updates",[]]